Antonietta Franco

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 8

Top Topics

Reactive Oxygen Species

Top Venues

Life (Basel, Switzerland)

The Journal of biological chemistry

Science (New York, N.Y.)

This page only lists publications with an associated author ORCID identifier.

Publications

Antonietta Franco, Jiajia Li, Daniel P Kelly, Ray E Hershberger, Ali J Marian, Renate M Lewis, Moshi Song, Xiawei Dang, Alina D Schmidt, Mary E Mathyer, John R Edwards, Cristina de Guzman Strong, Gerald W Dorn
A human mitofusin 2 mutation can cause mitophagic cardiomyopathy. eLife 12 (2023)
Antonietta Franco, Caroline E Walton, Xiawei Dang
Mitochondria Clumping vs. Mitochondria Fusion in CMT2A Diseases. Life (Basel, Switzerland) 12 (12) (2022)
Antonietta Franco, Caroline E Walton, Xiawei Dang
Mitochondria Clumping vs. Mitochondria Fusion in CMT2A Diseases. Life (Basel, Switzerland) 12 (12) (2022)
Antonietta Franco, Caroline E Walton, Xiawei Dang
Mitochondria Clumping vs. Mitochondria Fusion in CMT2A Diseases. Life (Basel, Switzerland) 12 (12) (2022)
Michele Ciccarelli, Daniela Sorriento, Antonella Fiordelisi, Jessica Gambardella, Antonietta Franco, Carmine Del Giudice, Marina Sala, Maria Gaia Monti, Alessia Bertamino, Pietro Campiglia, Marco Oliveti, Poggio Paolo, Giovanna Trinchese, Gina Cavaliere, Ersilia Cipolletta, Maria Pina Mollica, Domenico Bonaduce, Trimarco Bruno, Guido Iaccarino
Pharmacological inhibition of GRK2 improves cardiac metabolism and function in experimental heart failure. ESC heart failure 7 (4) (2020)
Anna Ballard, Rong Zeng, Allahdad Zarei, Christine Shao, Linda Cox, Hui Yan, Antonietta Franco, Gerald W Dorn, Roberta Faccio, Deborah J Veis
The tethering function of mitofusin2 controls osteoclast differentiation by modulating the Ca2+-NFATc1 axis. The Journal of biological chemistry 295 (19) (2020)
Antonietta Franco, Xiawei Dang, Emily K Walton, Joshua N Ho, Barbara Zablocka, Cindy Ly, Timothy M Miller, Robert H Baloh, Michael E Shy, Andrew S Yoo, Gerald W Dorn
Burst mitofusin activation reverses neuromuscular dysfunction in murine CMT2A. eLife 9 (2020)
Agostinho G Rocha, Antonietta Franco, Andrzej M Krezel, Jeanne M Rumsey, Justin M Alberti, William C Knight, Nikolaos Biris, Emmanouil Zacharioudakis, James W Janetka, Robert H Baloh, Richard N Kitsis, Daria-Mochly Rosen, R Reid Townsend, Evripidis Gavathiotis, Gerald W Dorn
MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A. Science (New York, N.Y.) 360 (6386) (2018)